Home › Funds › MetLife Investment Management, LLC › JNJ

MetLife Investment Management, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

MetLife Investment Management, LLC reported holding 532,673 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$141.0M, representing 0.66% of its reported portfolio and ranking #19 among its reported holdings. MetLife Investment Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)532.67K sh
Reported value held$141.02M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How MetLife Investment Management, LLC's JNJ position evolved

MetLife Investment Management, LLC first disclosed a stake in JNJ in Q3 2023 at 595,669 shares (US$92.8M). The position peaked in Q3 2026 at 532,673 shares, worth US$141.0M. Across 13 filings, MetLife Investment Management, LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 532,673 shares valued at US$141.0M — a reduction of -18,087 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 595.67K $92.78M New
Q4 2023 584.45K $91.61M Reduce
Q1 2024 563.72K $89.18M Reduce
Q2 2024 642.05K $93.84M Add
Q3 2024 626.05K $101.46M Reduce
Q4 2024 637.35K $92.17M Add
Q1 2025 625.43K $103.72M Reduce
Q2 2025 613.09K $93.65M Reduce
Q3 2025 597.52K $110.79M Reduce
Q4 2025 577.52K $119.52M Reduce
Q1 2026 563.04K $137.63M Reduce
Q2 2026 550.76K $139.88M Reduce
Q3 2026 532.67K $141.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has MetLife Investment Management, LLC held JNJ?

MetLife Investment Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MetLife Investment Management, LLC's current position in JNJ?

As of Q3 2026, MetLife Investment Management, LLC holds 532.67K shares of JNJ (JOHNSON & JOHNSON), valued at $141.02M, representing 0.66% of its reported portfolio and ranking #19.

Has MetLife Investment Management, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), MetLife Investment Management, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 532.67K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.